A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis

PURPOSE: Exploitation of altered glycosylation in cancer is a major goal for the design of new cancer therapy. Here designed a novel chimeric signal peptide-Galectin-3 conjugate (sGal-3) and investigated its ability to induce cancer-specific cell death by targeting aberrantly N-glycosylated cell sur...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Lee, Sok-Hyong, Rehman, Fatima K., Tyler, Kari, Yu, Bing, Zhang, Zhaobin, Osuka, Satoru, Zerrouqi, Abdessamad, Kaluzova, Milota, Hadjipanayis, Costas G., Cummings, Richard D., Olson, Jeffrey J., Devi, Narra S., Van Meir, Erwin G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580863/
https://ncbi.nlm.nih.gov/pubmed/31969339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3280
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky